The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Soldatov M.A.

Institute of Cerebrovascular Pathology and Stroke, Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency

Klimov L.V.

Institute of Cerebrovascular Pathology and Stroke of the Federal Center for Brain and Neurotechnology

Tolmachev A.P.

Institute of Cerebrovascular Pathology and Stroke of the Federal Center for Brain and Neurotechnology

Kiseleva T.V.

Scientific Research Institute of Healthcare Organization and Medical Management

Androfagina O.V.

Seredavin Samara Regional Clinical Hospital

Beketova E.M.

Pirogov Samara City Clinical Hospital

Belkina S.N.

Vladimirsky Moscow Regional Research Clinical Institute;
Voskresensk First Regional Hospital

Borisov D.N.

Kirov Regional Clinical Hospital

Karpov D.Yu.

City Hospital No. 5

Krasyuk M.S.

Bryansk City Hospital No. 1

Kucheryavaya M.V.

Sergiev Posad District Hospital

Minina Yu.D.

Seredavin Samara Regional Clinical Hospital

Novikov D.G.

Omsk State Medical University

Rogozhnikova N.V.

Novokuetsky Branch of the Barbarash Kemerovo Regional Clinical Cardiology Dispensary;
Novokuetsk State Institute of Advanced Medical Training — Branch of the Russian Medical Academy of Continuing Medical Education

Tabakman S.V.

Pirogov City Hospital No. 1

Telyatnik Yu.A.

Research Institute — Ochapovsky Regional Clinical Hospital No. 1

Tretyakov K.V.

Berzon Krasnoyarsk Interdistrict Clinical Hospital No. 20

Fadeeva A.S.

Vladivostok Clinical Hospital No. 1

Khan D.S.

Primorskaya Regional Clinical Hospital No. 1

Chirkov A.N.

Orenburg Regional Clinical Hospital

Marskaya N.A.

Institute of Cerebrovascular Pathology and Stroke, Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency

Shamalov N.A.

Pirogov National Research Medical University;
Federal Center for Brain Research and Neurotechnologies

Intravenous thrombolytic therapy of ischemic stroke with the drug Revelisa in real clinical practice: results of the IVT-AIS-R study

Authors:

Soldatov M.A., Klimov L.V., Tolmachev A.P., Kiseleva T.V., Androfagina O.V., Beketova E.M., Belkina S.N., Borisov D.N., Karpov D.Yu., Krasyuk M.S., Kucheryavaya M.V., Minina Yu.D., Novikov D.G., Rogozhnikova N.V., Tabakman S.V., Telyatnik Yu.A., Tretyakov K.V., Fadeeva A.S., Khan D.S., Chirkov A.N., Marskaya N.A., Shamalov N.A.

More about the authors

Views: 1513

Downloaded: 27


To cite this article:

Soldatov MA, Klimov LV, Tolmachev AP, et al. . Intravenous thrombolytic therapy of ischemic stroke with the drug Revelisa in real clinical practice: results of the IVT-AIS-R study. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(12‑2):42‑49. (In Russ.)
https://doi.org/10.17116/jnevro202212212242

Recommended articles:
Reve­rsible cere­bral vaso­constriction syndrome and ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12-2):17-23
New data on the pathophysiology of ischemic stroke: epigenetic mechanisms in focus. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12-2):24-29
Craniocerebral hypo­thermia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12-2):43-48
Local fibrinolisis in nontraumatic intraventricular hemo­rrhages. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(10):136-141

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.